Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t

Published on 26 Oct 2024 on The Wall Street Journal

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient...

Read the rest of the article

Start tracking your investments with Statfolio

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab i...

Benzinga 29 Oct 2024

Investors and analysts said they want to see improved profitability following the company's billi...

Reuters 28 Oct 2024

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient...

The Wall Street Journal 26 Oct 2024

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine...

Benzinga · via Yahoo Finance 23 Oct 2024

Smith is also Starboard's chief investment officer. Starboard has built a $1 billion position in...

Reuters 22 Oct 2024

(NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on i...

Benzinga · via AOL 22 Oct 2024

We recently compiled a list of the 10 Worst Performing Blue Chip Stocks in 2024. In this article,...

Insider Monkey · via Yahoo Finance 21 Oct 2024

We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The...

Insider Monkey · via Yahoo Finance 19 Oct 2024

We recently compiled a list of the 8 Good Stocks To Buy Right Now. In this article, we are going ...

Insider Monkey · via Yahoo Finance 18 Oct 2024

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going ...

Insider Monkey · via Yahoo Finance 18 Oct 2024